期刊文献+

TNF-α、INF-γ和EPO与肿瘤伴ACD造血功能低下的相关性 被引量:4

The relationship between TNF-α,INF-γ,EPO and reduced erythropoiesis in cancer with anemia of chronic disease
下载PDF
导出
摘要 目的:探讨肿瘤坏死因子α(TNF-α)、干扰素γ(INF-γ)和红细胞生成素(EPO)对肿瘤伴慢性病贫血(ACD)造血功能的影响。方法:检测肿瘤患者铁代谢参数;ELISA法检测患者血清TNF-α、IFN-γ和EPO水平;观察3种细胞因子及患者血清对骨髓红系集落生成单位(CFU-E)生成的影响。结果:肿瘤伴ACD患者血清EPO水平高于正常对照,而低于IDA患者;血清TNF-α、IFN-γ水平显著升高,且与血球压积、血清铁水平负相关;TNF-α、IFN-γ可抑制正常骨髓CFU-E生成,患者血清可抑制自身骨髓CFU-E生成,rhEPO可部分纠正细胞因子对CFU-E的抑制。结论:TNFα-、IFN-γ和EPO与肿瘤伴ACD造血功能低下有关。 Aim:To investigate the effect of EPO, TNF-α and IFN-γ on erythropoiesis in cancer with anemia of chronic disease (ACD). Methods: The iron metabolic parameters were measured by regular methods. EPO, TNF-α and IFN-γ levels in sera of cancers with ACD were detected by ELISA. The action of three cytokines and serum from patients themselves on erythroid colony forming unit-erythrocyte (CFU-E) growth of normal people's and patients' bone marrow were observed. Results: EPO levels in sera of cancers with ACD were higher than those in normal controls, while lower than those in cancers with iron-deficiency anemia. Levels of TNF-α and IFN-γ in sera of cancers with ACD were greatly increased and negatively correlated with hematocrit(Hct) and hemoglobin levels.- TNF-α and IFN-γ could inhibit normal bone marrow CFU-E growth. Bone marrow CFU-E yields of cancers with ACD could also be suppressed by their own sera. The inhibitory effects of TNF-α and IFN-γ on CFU-E growth could be partially reverted by adding rhEpo. erythropoiesis in cancer with anemia Conclusion:EPO, TNF-α and IFN-γ were associated with reduced of chronic disease.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2009年第2期139-142,共4页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家自然科学基金项目(30670902) 武汉市科委重点攻关项目(996008172)
关键词 肿瘤坏死因子α 干扰素Γ 红细胞生成素 肿瘤 慢性病贫血 tumor necrosis factor α(TNF-α) interferon γ(INF-γ) erythropoietin ( EPO ) cancer anemia of chronic disease
  • 相关文献

参考文献7

  • 1PESKIN B S,CARTER M J.Chronic cellular hypoxia as the prime cause of cancer:What is the de-oxygenating role of adulterated and improper ratios of polyunsaturated fatty acids when incorporated into cell membranes[J].Med Hypotheses,2008,70(2):298-304.
  • 2AGGARWAL B B,SHISHODIA S,SANDUR S K,et al.Inflammation and cancer:How hot is the link[J].Biochem Pharmacol,2006,72(11):1605-1621.
  • 3MILANO M,SCHNEIDER M.EPO in cancer anemia:Benefits and potential risks[J].Crit Rev Oncol Hematol,2007,62(2):119-125.
  • 4COSTA E,LIMA M,ALVES J M,et al.Inflammation,T-cell phenotypo,and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy[J].J Clin Immunol,2008,28(3):268-275.
  • 5THAWANI N,TAM M,CHANG K H,et al.Interferong mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo[J].Exp Hematol,2006,34(11):1451-1461.
  • 6MORCEAU F,SCHNEKENBURGER M,BLASIUS R,et al.Tumor necrosis factor alpha inhibits aclacinomycin Ainduced erythroid differentiation of K562 cells via GATA-1[J].Cancer Lett,2006,240(2):203-212.
  • 7JOHNSON D,BAYELE H,JOHNSTON K,et al.Tumout necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells[J]FEBS Lett,2004,573(1-3):195-201.

同被引文献24

引证文献4

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部